Concomitant administration of an insulin-resistance improving drug, AD-4833, with SU drugs: influence on the serum concentrations of SU drugs. - Ban,J.; Miyajima,T.; Tsumura,Y.; Inoue,T.; Nakamura,T.; Imamura,R.; Oe,M. (Jpn J Clin Exp Med, 1997)